https://www.selleckchem.com/pr....oducts/ertugliflozin
This trial will provide high-quality evidence of the effectiveness and safety of HCQ as PEP for COVID-19. The study design is unique due to the circumstances of the outbreak in a confined area among otherwise healthy adults, at a relatively early stage of its spread. Sri Lanka Clinical Trials Registry (SLCTR) SLCTR/2020/011 . Registered on 04 May 2020. Sri Lanka Clinical Trials Registry (SLCTR) SLCTR/2020/011 . Registered on 04 May 2020. Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease and rapidly escalat
Beğen
Yorum Yap
Paylaş
